In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: EPAM’s current price at $87.70 shows significant undervaluation against a high-confidence fair value of $175.90, implying upside potential exceeding 100%. Financial health is stable in liquidity and leverage but exhibits low growth (1.0/5), with Monte Carlo analysis indicating notable downside risk (47.2%) and high volatility (COV 31.16%). Valuation methods collectively reflect a broad opportunity range, but growth constraints heighten investment risk.